Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

Eur J Cancer

Multidisciplinary Oncological Centre Antwerp (MOCA), Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp and Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium.

Published: March 2022

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714294PMC
http://dx.doi.org/10.1016/j.ejca.2021.12.025DOI Listing

Publication Analysis

Top Keywords

antibody titres
4
titres third
4
third dose
4
dose sars-cov-2
4
sars-cov-2 bnt162b2
4
bnt162b2 vaccine
4
vaccine patients
4
patients cancer
4
antibody
1
third
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!